TRANSPOSAGEN BIOPHARMACEUTICALS, INC. SBIR Phase II Award,
A SBIR Phase II contract was awarded to TRANSPOSAGEN BIOPHARMACEUTICALS, INC. for $1,647,590.0 USD from the U.S. Department of Health & Human Services.
Currently, there are no issues on this topic.
Find more entities like TRANSPOSAGEN BIOPHARMACEUTICALS, INC. SBIR Phase II Award,
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.